Chronic and acute central nervous system (CNS) inflammation are contributors toward neurological injury associated with head trauma, stroke, infection, Parkinsons or Alzheimers disease. CNS inflammatory illnesses can also contribute toward risk of developing glioblastoma multiforme (GBM). With growing public interest in complementary and alternative medicines (CAMs), we conduct a high throughput (HTP) screening of N 1400 natural herbs, plants and over the counter (OTC) products for anti-inflammatory effects on lipopolysaccharide (LPS)/interferon gamma (IFNγ) activated C6 glioma cells. Validation studies were performed showing a pro-inflammatory profile of [LPS 3 µg/ml/ IFNγ 3 ng/ml] consistent with greater release [N 8.5 fold] of MCP-1, NO2−, cytokineinduced neutrophil chemo-attractants (CINC) 1, CINC 2a and CINC3. The data show no changes to the following, IL-13, TNF-a, fracktaline, leptin, LIX, GM-CSF, ICAM1, L-Selectin, activin A, agrin, IL-1α, MIP-3a, B72/CD86, NGF, IL1b, MMP-8, IL-1 R6, PDGF-AA, IL-2, IL-4, prolactin R, RAGE, IL-6, Thymus Chemokine-1, CNTF,IL-10 or TIMP-1. A HTP screening was conducted, where we employ an in vitro efficacy index (iEI) defined as the ratio of toxicity (LC 50 )/anti-inflammatory potency (IC 50 ). The iEI was precautionary to ensure biological effects were occurring in fully viable cells (ratio N 3.8) independent of toxicity. Using NO2− as a guideline molecule, the data show that 1.77% (25 of 1410 tested) had anti-inflammatory effects with iEI ratios N3.8 and IC 50 s b250 µg/ml. These include reference drugs (hydrocortisone, dexamethasone N6-(1-iminoethyl)-L-lysine and NSAIDS: diclofenac, tolfenamic acid), a histone deacetylase inhibitor (apicidin) and the following natural products; Ashwaganda (Withania somnifera), Elecampagne Root (Inula helenium), Feverfew (Tanacetum parthenium), Green Tea (Camellia sinensis), Turmeric Root (Curcuma longa) Ganthoda (Valeriana wallichii), Tansy (Tanacetum vulgare), Maddar Root (Rubia tinctoria), Red Sandle wood (Pterocarpus santalinus), Bay Leaf (Laurus nobilis, Lauraceae), quercetin, cardamonin, fisetin, EGCG, biochanin A, galangin, apigenin and curcumin. The herb with the largest iEI was Ashwaganda where the IC 50 /LC 50 was 11.1/N1750.0 μg/ml, and the compound with the greatest iEI was quercetin where the IC 50 /LC 50 was 10.0/N363.6 μg/ml. These substances also downregulate the production of iNOS expression and attenuate CINC-3 release. In summary, this HTP screening provides guideline information about the efficacy of natural products that could prevent inflammatory processes associated with neurodegenerative disease and aggressive glioma tumor growth.
1. Introduction
CNS inflammation, glial cells and neurodegeneration
Age related central nervous system (CNS) degenerative diseases such as Parkinson's (PD) and Alzheimer's disease (AD) are becoming significant global health concerns. Inflammatory processes occurring within CNS (by glial cells) can contribute toward vascular damage (Doyle et al., 2015; Weaver et al., 2010) , neurological insult (Bodnar et al., 2015; Garcia et al., 2016) and destruction to the blood brain barrier (BBB). (Adelson et al., 1998) While CNS glial cells exert a positive influential role in neurodevelopment, neuronal homeostasis and detoxification, on the flip side, age related pro-inflammatory neurodegeneration can be evoked by head trauma (Lopez-Rodriguez et al., 2015) , ischemia (Li et al., 2015c) infection (Ben Haim et al., 2015a) lysosomal storage disease (Rama Rao and Kielian, 2015) and protein aggregates of amyloid β (Aβ) (Ben Haim et al., 2015a) and α-synuclein A53T (Ben Haim et al., 2015a , Yang et al., 2015 common to AD and PD, respectively. Once neuronal insult has taken place, reactive gliosis (Mohn and Koob, 2015) can Journal of Neuroimmunology 302 (2017) 10-19 
